Citation: Gb. Varty et Ga. Higgins, DOPAMINE AGONIST-INDUCED HYPOTHERMIA AND DISRUPTION OF PREPULSE INHIBITION - EVIDENCE FOR A ROLE OF D-3 RECEPTORS, Behavioural pharmacology, 9(5-6), 1998, pp. 445-455
Citation: Dl. Kirkby et Ga. Higgins, CHARACTERIZATION OF PERFORANT PATH LESIONS IN RODENT MODELS OF MEMORYAND ATTENTION, European journal of neuroscience, 10(3), 1998, pp. 823-838
Authors:
ANDERSON R
BARNES JC
GRAY RA
HIGGINS GA
LARGE CH
Citation: R. Anderson et al., BEHAVIORAL, PHYSIOLOGICAL AND MORPHOLOGICAL ANALYSIS OF AMYLOID-PRECURSOR PROTEIN KNOCKOUT MICE, European journal of neuroscience, 10, 1998, pp. 15504-15504
Authors:
ANDERSON R
BARNES JC
BLISS TVP
CAIN DP
CAMBON K
DAVIES HA
ERRINGTON ML
FELLOWS LA
GRAY RA
HOH T
STEWART M
LARGE CH
HIGGINS GA
Citation: R. Anderson et al., BEHAVIORAL, PHYSIOLOGICAL AND MORPHOLOGICAL ANALYSIS OF A LINE OF APOLIPOPROTEIN-E KNOCKOUT MOUSE, Neuroscience, 85(1), 1998, pp. 93-110
Citation: E. Southam et al., LAMOTRIGINE INHIBITS MONOAMINE UPTAKE IN-VITRO AND MODULATES 5-HYDROXYTRYPTAMINE UPTAKE IN RATS, European journal of pharmacology, 358(1), 1998, pp. 19-24
Authors:
MCALLISTER KHM
PRATT JA
HIGGINS GA
BEATTIE DT
Citation: Khm. Mcallister et al., EFFECT OF THE NK1 RECEPTOR ANTAGONIST, GR205171, ON APOMORPHINE-INDUCED FOS-EXPRESSION IN THE RAT BRAIN-STEM, British Journal of Pharmacology, 123, 1998, pp. 223-223
Citation: Pj. Fletcher et Ga. Higgins, DIFFERENTIAL-EFFECTS OF ONDANSETRON AND ALPHA-FLUPENTIXOL ON RESPONDING FOR CONDITIONED REWARD, Psychopharmacology, 134(1), 1997, pp. 64-72
Citation: Ga. Higgins et al., NEW SIMULATION TECHNOLOGIES FOR SURGICAL TRAINING AND CERTIFICATION CURRENT STATUS AND FUTURE PROJECTIONS, Presence, 6(2), 1997, pp. 160-172
Authors:
HIGGINS GA
MEGLAN DA
RAJU R
MERRIL JR
MERRIL GL
Citation: Ga. Higgins et al., TELEOS(TM) - DEVELOPMENT OF A SOFTWARE TOOLKIT FOR AUTHORING VIRTUAL MEDICAL ENVIRONMENTS, Presence, 6(2), 1997, pp. 241-252
Citation: Ga. Higgins et al., APOLIPOPROTEIN-E AND ALZHEIMERS-DISEASE - A REVIEW OF RECENT STUDIES, Pharmacology, biochemistry and behavior, 56(4), 1997, pp. 675-685
Citation: Gb. Varty et Ga. Higgins, INVESTIGATIONS INTO THE NATURE OF A 7-OH-DPAT DISCRIMINATIVE CUE - COMPARISON WITH D-AMPHETAMINE, European journal of pharmacology, 339(2-3), 1997, pp. 101-107
Citation: R. Anderson et al., MICE LACKING THE APOLIPOPROTEIN-E GENE DO NOT SHOW ANY MARKED CHOLINERGIC DEFICITS, British Journal of Pharmacology, 120, 1997, pp. 133-133
Authors:
HARDMAN R
EVANS DJ
FELLOWS L
HAYES B
RUPNIAK HT
BARNES JC
HIGGINS GA
Citation: R. Hardman et al., EVIDENCE FOR RECOVERY OF SPATIAL-LEARNING FOLLOWING ENTORHINAL CORTEXLESIONS IN MICE, Brain research, 758(1-2), 1997, pp. 187-200
Citation: Dl. Kirkby et al., EFFECTS OF ANTICHOLINESTERASE DRUGS TACRINE AND E2020, THE 5-HT3 ANTAGONIST ONDANSETRON, AND THE H-3 ANTAGONIST THIOPERAMIDE, IN MODELS OF COGNITION AND CHOLINERGIC FUNCTION, Behavioural pharmacology, 7(6), 1996, pp. 513-525
Citation: Gb. Varty et Ga. Higgins, EXAMINATION OF DRUG-INDUCED AND ISOLATION-INDUCED DISRUPTIONS OF PREPULSE INHIBITION AS MODELS TO SCREEN ANTIPSYCHOTIC-DRUGS, Psychopharmacology, 122(1), 1995, pp. 15-26
Authors:
WANG Y
JOHARCHI N
FLETCHER PJ
SELLERS EM
HIGGINS GA
Citation: Y. Wang et al., FURTHER-STUDIES TO EXAMINE THE NATURE OF DEXFENFLURAMINE-INDUCED SUPPRESSION OF HEROIN SELF-ADMINISTRATION, Psychopharmacology, 120(2), 1995, pp. 134-141
Citation: Dnc. Jones et al., AGE-ASSOCIATED IMPAIRMENTS IN A TEST OF ATTENTION - EVIDENCE FOR INVOLVEMENT OF CHOLINERGIC SYSTEMS, The Journal of neuroscience, 15(11), 1995, pp. 7282-7292
Citation: Dl. Kirkby et al., INFLUENCE OF PREFEEDING AND SCOPOLAMINE UPON PERFORMANCE IN A DELAYEDMATCHING-TO-POSITION TASK, Behavioural brain research, 67(2), 1995, pp. 221-227
Citation: Gb. Varty et Ga. Higgins, REVERSAL OF A DIZOCILPINE-INDUCED DISRUPTION OF PREPULSE INHIBITION OF AN ACOUSTIC STARTLE RESPONSE BY THE 5-HT2 RECEPTOR ANTAGONIST KETANSERIN, European journal of pharmacology, 287(2), 1995, pp. 201-205
Citation: Dl. Kirkby et al., A BEHAVIORAL-COMPARISON BETWEEN THE ANTICHOLINESTERASE DRUGS TACRINE AND E2020, British Journal of Pharmacology, 114, 1995, pp. 335-335